Annals of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2023-03-07 kfxieyulei 来自北京

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：机制;脊髓
经验分享：一周拒稿，没送外审

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-01-27 ms1000000995331571

under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下

212 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2020-08-28 peter

要上传原始数据吗？

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-07-04 爱科研的小博士

偏重的研究方向：肿瘤
经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-08-18 1e16519dm57(暂无匿称)

偏重的研究方向：肿瘤
经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？

69 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-09-15 薛定谔的虎

偏重的研究方向：肿瘤;临床
经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌

65 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-09-30 14881b46m04(暂无昵称)

友友们，纯生信的接收吗

64 0

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-03-21 木木木木木木林123

投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志

139 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-09-01 ms4000000814349036

投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2118067, encodeId=3b30211806e71, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：机制;脊髓 经验分享：一周拒稿，没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNFv6gVJApyW8D8XJEcMG2c02c6o20Z9BYv82ibOrK5jvDZZbrALKy8gewADLODt66l8p9UlK9MYA/132, createdBy=09955292012, createdName=kfxieyulei, createdTime=Tue Mar 07 10:14:20 CST 2023, time=2023-03-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1188520, encodeId=678a1188520c8, content=under review （step 3）一个月，现在变成under review （step 2）是啥意思？请老师们指导一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Thu Jan 27 08:55:55 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814472, encodeId=72cb8144e2be, content=要上传原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65403699, createdName=peter, createdTime=Fri Aug 28 08:04:54 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249045, encodeId=deab124904530, content=偏重的研究方向：肿瘤;临床 经验分享：一审3个月，返修后第二天查看状态变为Under Review (Step 6)，请问这个大概啥时候能有结果啊，看前辈们的周期临近毕业很慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cce5586885, createdName=薛定谔的虎, createdTime=Thu Sep 15 10:01:47 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091143, encodeId=78482091143cf, content=友友们，纯生信的接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/8471a11dcbfc40878486067adafce4ea/d35084676c3448b1822f77cc3a37abc4.jpg, createdBy=c6245308775, createdName=14881b46m04(暂无昵称), createdTime=Fri Sep 30 09:04:12 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204544, encodeId=4a671204544c1, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：两三天就被拒了，还推荐他们零点几分的姊妹杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Mon Mar 21 09:40:21 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242558, encodeId=16c51242558b5, content=投稿了，但是现在官网打不开了，试了很多方法都不行，是网站在维护吗？有小伙伴出现了同样的情况吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3165444193, createdName=ms4000000814349036, createdTime=Thu Sep 01 21:15:01 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242022, encodeId=6bf012420228e, content=偏重的研究方向：肿瘤 经验分享：请问under review 的各个step是什么意思呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce795530837, createdName=ms5000000812180894, createdTime=Tue Aug 30 10:56:52 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-08-30 ms5000000812180894

偏重的研究方向：肿瘤
经验分享：请问under review 的各个step是什么意思呀？

56 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务